We do not. The reason is that in the present language, “a person who sells” captures everyone in the distribution chain, with the exception of the patient, because the definition of “sell” in the Food and Drugs Act includes, “offer for sale, expose for sale, have in possession for sale and distribute, whether or not the distribution is made for consideration”. So a recall order would do what it's supposed to do, which is to apply to the manufacturer, distributor, wholesaler, retailer, health care practitioners, and pharmacists to get unsafe drugs out of the supply chain.
The language of the proposed motion, “holder of a therapeutic product authorization” would restrict the recall authority to therapeutic product authorization holders only and would narrow the recall powers. So we don't support it because of the apparently unintended consequences.